Cargando…

Continuous high-dose infusion of doripenem in a pneumonia patient infected by carbapenem-resistant Pseudomonas aeruginosa: a case report

BACKGROUND: Despite the high mortality of patients with sepsis and carbapenem-resistant bacteria infection, appropriate antimicrobial therapies are yet to be established. Here, we have reported the case of a patient with pneumonia that subsequently developed by carbapenem-resistant Pseudomonas aerug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oda, Kazutaka, Kamohara, Hidenobu, Katanoda, Tomomi, Hashiguchi, Yumi, Iwamura, Koji, Nosaka, Kisato, Jono, Hirofumi, Saito, Hideyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613258/ https://www.ncbi.nlm.nih.gov/pubmed/31321067 http://dx.doi.org/10.1186/s40780-019-0144-4

Ejemplares similares

Lowered Risk of Nephrotoxicity through Intervention against the Combined Use of Vancomycin and Tazobactam/Piperacillin: A Retrospective Cohort Study
por: Oda, Kazutaka, et al.
Publicado: (2021)

Clinical evaluation of an authorized medical equipment based on high performance liquid chromatography for measurement of serum voriconazole concentration
por: Oda, Kazutaka, et al.
Publicado: (2021)

Fingolimod Promotes Antibacterial Effect of Doripenem against Carbapenem-Resistant Escherichia coli
por: Jin, Hye-Won, et al.
Publicado: (2022)

In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
por: Hu, Yi-Fan, et al.
Publicado: (2016)

In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
por: Loho, Tonny, et al.
Publicado: (2018)

Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities
por: Walsh, Fiona
Publicado: (2007)

Structural Analysis of The OXA-48 Carbapenemase Bound to A “Poor” Carbapenem Substrate, Doripenem
por: Papp-Wallace, Krisztina M., et al.
Publicado: (2019)

Resistance of Animal Strains of Pseudomonas aeruginosa to Carbapenems
por: Haenni, Marisa, et al.
Publicado: (2017)

Carbapenem-resistant Pseudomonas aeruginosa and carbapenem use in Japan: an ecological study
por: Terahara, Fumitaka, et al.
Publicado: (2019)

Characterization of Pseudomonas aeruginosa with discrepant carbapenem susceptibility profile
por: Pragasam, Agila K., et al.
Publicado: (2016)

Distinctive Regulation of Carbapenem Susceptibility in Pseudomonas aeruginosa by Hfq
por: Sonnleitner, Elisabeth, et al.
Publicado: (2020)

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2018)

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2017)

A novel step‐down infusion method of barbiturate therapy: Its safety and effectiveness for intracranial pressure control
por: Yamakawa, Yukako, et al.
Publicado: (2021)

Carbapenem Susceptibility and Multidrug-Resistance in Pseudomonas aeruginosa Isolates in Egypt
por: Hashem, Hany, et al.
Publicado: (2016)

Spread of Carbapenem Resistance by Transposition and Conjugation Among Pseudomonas aeruginosa
por: van der Zee, Anneke, et al.
Publicado: (2018)

Ceftolozane/Tazobactam Resistance and Mechanisms in Carbapenem-Nonsusceptible Pseudomonas aeruginosa
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2021)

Genomic characterization of carbapenem-non-susceptible Pseudomonas aeruginosa in Singapore
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2021)

Epidemiology, Molecular Characteristics, and Virulence Factors of Carbapenem-Resistant Pseudomonas aeruginosa Isolated from Patients with Urinary Tract Infections
por: Park, Yumi, et al.
Publicado: (2022)

Epidemiology of carbapenem non-susceptible Pseudomonas aeruginosa isolates in Eastern Algeria
por: Meradji, Samah, et al.
Publicado: (2015)

Detection of Metallo-Beta Lactamases Among Carbapenem-Resistant Pseudomonas aeruginosa
por: Farajzadeh Sheikh, Ahmad, et al.
Publicado: (2014)

Carbapenem-resistant Pseudomonas aeruginosa: association with virulence genes and biofilm formation
por: Rossi Gonçalves, Iara, et al.
Publicado: (2016)

Clinical Significance of Carbapenem-Tolerant Pseudomonas aeruginosa Isolated in the Respiratory Tract
por: Azuma, Momoyo, et al.
Publicado: (2020)

Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa, Zhejiang Province, China
por: Hu, Yan-Yan, et al.
Publicado: (2019)

Challenges of Carbapenem-resistant Pseudomonas aeruginosa in Infection Control and Antibiotic Management
por: Kim, Young Jin, et al.
Publicado: (2024)

Population pharmacokinetic analysis of doripenem for Japanese patients in intensive care unit
por: Nonoshita, Ko, et al.
Publicado: (2020)

Continuous infusion versus intermittent infusion of ceftazidime for the treatment of pneumonia caused by Pseudomonas aeruginosa
por: Lorente, L, et al.
Publicado: (2005)

Characteristics of doripenem: a new broad-spectrum antibiotic
por: Alvarez-Lerma, Francisco, et al.
Publicado: (2009)

Correlation Between Virulence Genotype and Fluoroquinolone Resistance in Carbapenem-Resistant Pseudomonas aeruginosa
por: Cho, Hye Hyun, et al.
Publicado: (2014)

Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015
por: Walters, Maroya Spalding, et al.
Publicado: (2019)

Mechanisms for Rapid Evolution of Carbapenem Resistance in a Clinical Isolate of Pseudomonas aeruginosa
por: Xu, Congjuan, et al.
Publicado: (2020)

Carbapenem-resistant Pseudomonas Aeruginosa Originating from Farm Animals and People in Egypt
por: Elshafiee, Esraa A., et al.
Publicado: (2019)

85. The Impact of Carbapenem-Sparing Interventions on the Evolution of Resistance in Pseudomonas aeruginosa in the USA
por: Townsend, Jeffrey, et al.
Publicado: (2020)

Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa
por: Hu, Yanyan, et al.
Publicado: (2021)

Association between Consumption of Fluoroquinolones and Carbapenems and Their Resistance Rates in Pseudomonas aeruginosa in Argentina
por: Boni, Silvia, et al.
Publicado: (2022)

Anti-bacterial mechanism of baicalin-tobramycin combination on carbapenem-resistant Pseudomonas aeruginosa
por: Jin, Li-Min, et al.
Publicado: (2023)

Investigating the Antagonistic Effect of Indigenous Probiotics on Carbapenem-Resistant Pseudomonas aeruginosa Strains
por: Ghiaei, Azita, et al.
Publicado: (2023)

Risk Factors and Outcomes of Patients with Carbapenem-Resistant Pseudomonas aeruginosa Bloodstream Infection
por: Wei, Xianzhen, et al.
Publicado: (2023)

Evolving landscape of carbapenem-resistant Pseudomonas aeruginosa at a single centre in the USA
por: Sakurai, Aki, et al.
Publicado: (2023)

Combination of AS101 and Mefloquine Inhibits Carbapenem-Resistant Pseudomonas aeruginosa in vitro and in vivo
por: Li, Rongrong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lujsfcui30og4g47hit6ul8lfa